TR-584: Indole-3-Carbinol (CASRN 700-06-1) in F344/N Rats

Total Page:16

File Type:pdf, Size:1020Kb

TR-584: Indole-3-Carbinol (CASRN 700-06-1) in F344/N Rats NTP TECHNICAL REPORT ON THE TOXICOLOGY STUDIES OF INDOLE-3-CARBINOL (CASRN 700-06-1) IN F344/N RATS AND B6C3F1/N MICE AND TOXICOLOGY AND CARCINOGENESIS STUDIES OF INDOLE-3-CARBINOL IN HARLAN SPRAGUE DAWLEY RATS AND B6C3F1/N MICE (GAVAGE STUDIES) NTP TR 584 JULY 2017 NTP Technical Report on the Toxicology Studies of Indole-3-carbinol (CASRN 700-06-1) in F344/N Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of Indole-3-carbinol in Harlan Sprague Dawley Rats and B6C3F1/N Mice (Gavage Studies) Technical Report 584 July 2017 National Toxicology Program Public Health Service U.S. Department of Health and Human Services ISSN: 2378-8925 Research Triangle Park, North Carolina, USA Indole-3-carbinol, NTP TR 584 Foreword The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Technical Report series began in 1976 with carcinogenesis studies conducted by the National Cancer Institute. In 1981, this bioassay program was transferred to NTP. The studies described in the Technical Report series are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected substances in laboratory animals (usually two species, rats and mice). Substances selected for NTP toxicity and carcinogenicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure. The interpretive conclusions presented in NTP Technical Reports are based only on the results of these NTP studies. Extrapolation of these results to other species, including characterization of hazards and risks to humans, requires analyses beyond the intent of these reports. Selection per se is not an indicator of a substance’s carcinogenic potential. NTP conducts its studies in compliance with its laboratory health and safety guidelines and FDA Good Laboratory Practice Regulations and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use are in accordance with the Public Health Service Policy on Humane Care and Use of Animals. Studies are subjected to retrospective quality assurance audits before being presented for public review. The NTP Technical Reports are available free of charge on the NTP website and cataloged in PubMed, a free resource developed and maintained by the National Library of Medicine (part of the National Institutes of Health). Data for these studies are included in NTP’s Chemical Effects in Biological Systems database. For questions about the reports and studies, please email NTP or call 984-287-3211. ii Indole-3-carbinol, NTP TR 584 Table of Contents Foreword.................................................................................................................................... ii Tables ........................................................................................................................................ vi Figures ......................................................................................................................................vii About This Report ...................................................................................................................... ix Explanation of Levels of Evidence of Carcinogenic Activity .....................................................xii Peer Review ............................................................................................................................. xiv Publication Details .................................................................................................................... xv Abstract ................................................................................................................................... xvi Three-month Study in F344/N Rats ..................................................................................... xvi Three-month Study in B6C3F1/N Mice ............................................................................... xvi Two-year Study in Sprague Dawley Rats ............................................................................ xvii Two-year Study in B6C3F1/N Mice ................................................................................... xvii Genetic Toxicology ...........................................................................................................xviii Conclusions .......................................................................................................................xviii Introduction ................................................................................................................................ 1 Chemical and Physical Properties ........................................................................................... 1 Production, Use, and Human Exposure ................................................................................... 1 Regulatory Status ................................................................................................................... 2 Absorption, Distribution, Metabolism, and Excretion ............................................................. 2 Experimental Animals ..................................................................................................... 2 Humans ........................................................................................................................... 3 Toxicity .................................................................................................................................. 3 Experimental Animals ..................................................................................................... 3 Humans ........................................................................................................................... 5 Reproductive and Developmental Toxicity ............................................................................. 6 Experimental Animals ..................................................................................................... 6 Humans ........................................................................................................................... 6 Carcinogenicity ...................................................................................................................... 6 Experimental Animals ..................................................................................................... 6 Humans ........................................................................................................................... 7 Genetic Toxicity ..................................................................................................................... 7 Study Rationale ...................................................................................................................... 8 Materials and Methods ................................................................................................................ 9 Procurement and Characterization .......................................................................................... 9 Indole-3-carbinol ............................................................................................................. 9 Corn Oil .......................................................................................................................... 9 Preparation and Analysis of Dose Formulations .................................................................... 10 Animal Source ...................................................................................................................... 10 Animal Welfare .................................................................................................................... 10 Three-month Studies ............................................................................................................ 11 iii Indole-3-carbinol, NTP TR 584 Two-year Studies .................................................................................................................. 13 Study Design ................................................................................................................. 13 Clinical Examinations and Pathology............................................................................. 13 Statistical Methods ............................................................................................................... 18 Survival Analyses .......................................................................................................... 18 Calculation of Incidence ................................................................................................ 18 Analysis of Neoplasm and Nonneoplastic Lesion
Recommended publications
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • MINI-REVIEW Cruciferous Vegetables: Dietary Phytochemicals for Cancer Prevention
    DOI:http://dx.doi.org/10.7314/APJCP.2013.14.3.1565 Glucosinolates from Cruciferous Vegetables for Cancer Chemoprevention MINI-REVIEW Cruciferous Vegetables: Dietary Phytochemicals for Cancer Prevention Ahmad Faizal Abdull Razis1*, Noramaliza Mohd Noor2 Abstract Relationships between diet and health have attracted attention for centuries; but links between diet and cancer have been a focus only in recent decades. The consumption of diet-containing carcinogens, including polycyclic aromatic hydrocarbons and heterocyclic amines is most closely correlated with increasing cancer risk. Epidemiological evidence strongly suggests that consumption of dietary phytochemicals found in vegetables and fruit can decrease cancer incidence. Among the various vegetables, broccoli and other cruciferous species appear most closely associated with reduced cancer risk in organs such as the colorectum, lung, prostate and breast. The protecting effects against cancer risk have been attributed, at least partly, due to their comparatively high amounts of glucosinolates, which differentiate them from other vegetables. Glucosinolates, a class of sulphur- containing glycosides, present at substantial amounts in cruciferous vegetables, and their breakdown products such as the isothiocyanates, are believed to be responsible for their health benefits. However, the underlying mechanisms responsible for the chemopreventive effect of these compounds are likely to be manifold, possibly concerning very complex interactions, and thus difficult to fully understand. Therefore,
    [Show full text]
  • Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers
    molecules Review Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers Prabhakaran Soundararajan and Jung Sun Kim * Genomics Division, Department of Agricultural Bio-Resources, National Institute of Agricultural Sciences, Rural Development Administration, Wansan-gu, Jeonju 54874, Korea; [email protected] * Correspondence: [email protected] Academic Editor: Gautam Sethi Received: 15 October 2018; Accepted: 13 November 2018; Published: 15 November 2018 Abstract: Glucosinolates (GSL) are naturally occurring β-D-thioglucosides found across the cruciferous vegetables. Core structure formation and side-chain modifications lead to the synthesis of more than 200 types of GSLs in Brassicaceae. Isothiocyanates (ITCs) are chemoprotectives produced as the hydrolyzed product of GSLs by enzyme myrosinase. Benzyl isothiocyanate (BITC), phenethyl isothiocyanate (PEITC) and sulforaphane ([1-isothioyanato-4-(methyl-sulfinyl) butane], SFN) are potential ITCs with efficient therapeutic properties. Beneficial role of BITC, PEITC and SFN was widely studied against various cancers such as breast, brain, blood, bone, colon, gastric, liver, lung, oral, pancreatic, prostate and so forth. Nuclear factor-erythroid 2-related factor-2 (Nrf2) is a key transcription factor limits the tumor progression. Induction of ARE (antioxidant responsive element) and ROS (reactive oxygen species) mediated pathway by Nrf2 controls the activity of nuclear factor-kappaB (NF-κB). NF-κB has a double edged role in the immune system. NF-κB induced during inflammatory is essential for an acute immune process. Meanwhile, hyper activation of NF-κB transcription factors was witnessed in the tumor cells. Antagonistic activity of BITC, PEITC and SFN against cancer was related with the direct/indirect interaction with Nrf2 and NF-κB protein.
    [Show full text]
  • Synthesis of Isothiocyanates Using DMT/NMM/Tso− As a New Desulfurization Reagent
    molecules Article Synthesis of Isothiocyanates Using DMT/NMM/TsO− as a New Desulfurization Reagent Łukasz Janczewski 1,* , Dorota Kr˛egiel 2 and Beata Kolesi ´nska 1 1 Faculty of Chemistry, Institute of Organic Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924 Lodz, Poland; [email protected] 2 Department of Environmental Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Wolczanska 171/173, 90-924 Lodz, Poland; [email protected] * Correspondence: [email protected] Abstract: Thirty-three alkyl and aryl isothiocyanates, as well as isothiocyanate derivatives from esters of coded amino acids and from esters of unnatural amino acids (6-aminocaproic, 4-(aminomethyl)benzoic, and tranexamic acids), were synthesized with satisfactory or very good yields (25–97%). Synthesis was performed in a “one-pot”, two-step procedure, in the presence of organic base (Et3N, DBU or NMM), and carbon disulfide via dithiocarbamates, with 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4- methylmorpholinium toluene-4-sulfonate (DMT/NMM/TsO−) as a desulfurization reagent. For the synthesis of aliphatic and aromatic isothiocyanates, reactions were carried out in a microwave reactor, and selected alkyl isothiocyanates were also synthesized in aqueous medium with high yields (72–96%). Isothiocyanate derivatives of L- and D-amino acid methyl esters were synthesized, under conditions without microwave radiation assistance, with low racemization (er 99 > 1), and their absolute configuration was confirmed by circular dichroism. Isothiocyanate derivatives of natural and unnatural amino acids were evaluated for antibacterial activity on E. coli and S. aureus bacterial strains, where the Citation: Janczewski, Ł.; Kr˛egiel,D.; most active was ITC 9e.
    [Show full text]
  • Figure 1. Metabolism of Glucoraphanin and Glucobrassicin to Biologically Active Metabolites
    Legend to Figures: Figure 1. Metabolism of glucoraphanin and glucobrassicin to biologically active metabolites. (A) Sulforaphane is released from glucoraphanin by the plant enzyme myrosinase. Red dashed arrow marks the reactive carbon atom subject to glutathione conjugation. (B) Sulforaphane is metabolized via the mercapturic acid pathway into active metabolites. Glutathione-S-transferase (GST) first conjugates a GSH molecule (Glu-Cys-Gly) to the reactive carbon on sulforaphane. Glutamate is then removed by γ- glutamyltranspeptidase (GTP), followed by removal of the glycine residue by cysteinylglycinase (CGase). Cysteine is then acetylated by an acetyltransferase (AT) to sulforaphane-N-acetylcysteine, which is excreted in the urine. (C) Indole-3-carbinol is released from the glucosinolate glucobrassicin by myrosinase and undergoes spontaneous condensation in the acidic environment of the gut. Diindolylmethane (DIM) is the most abundant post-absorption acid condensation product. Acid condensation products can be modified further post-absorption. LTr1: Linear trimer 1. LTr2: Linear trimer 2. Structures from PubChem at National Center for Biotechnology Information (NCBI). Figure 2. Selected non-epigenetic effects of sulforaphane and I3C/DIM on prostate cancer cells. Sulforaphane (SFN) and I3C/DIM inhibit the Akt signaling axis, a signaling pathway often hyperactive in prostate cancer. Inhibition of this pathway decreases pro-survival signaling by mTOR, Akt, and NFkB. Sulforaphane and I3C/DIM treatment also lead to changes in gene expression (blue arrow) that trigger growth arrest and apoptosis. The expression of proteins controlling the cell cycle (e.g. p21, p27, CDK6) are altered to effect growth arrest, and apoptosis is finally induced through the mitochondrial pathway. Abbreviations: AR – Androgen Receptor, CDK6 – cyclin dependant kinase 6, IAP – inhibitors of apoptosis.
    [Show full text]
  • WO 2014/149829 Al 25 September 2014 (25.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/149829 Al 25 September 2014 (25.09.2014) P O P C T (51) International Patent Classification: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, A23L 1/22 (2006.01) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (21) International Application Number: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, PCT/US2014/021 110 TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (22) International Filing Date: ZW. 6 March 2014 (06.03.2014) (84) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (26) Publication Language: English UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (30) Priority Data: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 61/788,528 15 March 2013 (15.03.2013) US EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, 61/945,500 27 February 2014 (27.02.2014) US MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (71) Applicant: AFB INTERNATIONAL [US/US]; 3 Re KM, ML, MR, NE, SN, TD, TG).
    [Show full text]
  • Broccoli Sprout Beverage Is Safe for Thyroid Hormonal and Autoimmune Status: Results of a 12-Week Randomized Trial T
    Food and Chemical Toxicology 126 (2019) 1–6 Contents lists available at ScienceDirect Food and Chemical Toxicology journal homepage: www.elsevier.com/locate/foodchemtox Broccoli sprout beverage is safe for thyroid hormonal and autoimmune status: Results of a 12-week randomized trial T Dionysios V. Chartoumpekisa,2, Panos G. Zirosb, Jian-Guo Chenc, John D. Groopmand, ∗ Thomas W. Kenslera,1,3, Gerasimos P. Sykiotisb, ,1 a Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, 15261, USA b Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, Lausanne, Switzerland c Department of Epidemiology, Qidong Liver Cancer Institute, Qidong, Jiangsu, China d Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA ARTICLE INFO ABSTRACT Keywords: Sulforaphane is a redox-active natural product present in cruciferous vegetables like broccoli. Broccoli sprout- Nrf2 derived products are promising agents for the prevention of oxidative stress-related diseases, but some have long Thyroid been suspected of thyroidal toxicity. Recent findings also raise the possibility that long-term exposure to sul- Sulforaphane foraphane, or to other natural substances or drugs that modulate the activity of the transcription factor Nrf2 Glucoraphanin (NFE2-related factor 2) may lead to thyroid dysfunction or thyroid autoimmune disease, questioning the safety Broccoli sprout beverage of trials with sulforaphane-containing products. Previous studies addressing possible effects of sulforaphane- Clinical trial related compounds from natural product extracts on the thyroid were quite short and/or inconsistent. To in- vestigate whether long-term exposure to a beverage enriched with sulforaphane and its precursor glucoraphanin may affect thyroid function, we analyzed biochemical measures of thyroid function and thyroid autoimmunity in 45 female participants in a randomized clinical trial at baseline and after 84 days of beverage administration.
    [Show full text]
  • Isothiocyanates from Cruciferous Vegetables
    Isothiocyanates from Cruciferous Vegetables: Kinetics, Biomarkers and Effects Martijn Vermeulen Promotoren Prof. dr. Peter J. van Bladeren Hoogleraar Toxicokinetiek en Biotransformatie, leerstoelgroep Toxicologie, Wageningen Universiteit Prof. dr. ir. Ivonne M.C.M. Rietjens Hoogleraar Toxicologie, Wageningen Universiteit Copromotor Dr. Wouter H.J. Vaes Productmanager Nutriënten en Biomarker analyse, TNO Kwaliteit van Leven, Zeist Promotiecommissie Prof. dr. Aalt Bast Universiteit Maastricht Prof. dr. ir. M.A.J.S. (Tiny) van Boekel Wageningen Universiteit Prof. dr. Renger Witkamp Wageningen Universiteit Prof. dr. Ruud A. Woutersen Wageningen Universiteit / TNO, Zeist Dit onderzoek is uitgevoerd binnen de onderzoeksschool VLAG (Voeding, Levensmiddelen- technologie, Agrobiotechnologie en Gezondheid) Isothiocyanates from Cruciferous Vegetables: Kinetics, Biomarkers and Effects Martijn Vermeulen Proefschrift ter verkrijging van de graad van doctor op gezag van de rector magnificus van Wageningen Universiteit, prof. dr. M.J. Kropff, in het openbaar te verdedigen op vrijdag 13 februari 2009 des namiddags te half twee in de Aula. Title Isothiocyanates from cruciferous vegetables: kinetics, biomarkers and effects Author Martijn Vermeulen Thesis Wageningen University, Wageningen, The Netherlands (2009) with abstract-with references-with summary in Dutch ISBN 978-90-8585-312-1 ABSTRACT Cruciferous vegetables like cabbages, broccoli, mustard and cress, have been reported to be beneficial for human health. They contain glucosinolates, which are hydrolysed into isothiocyanates that have shown anticarcinogenic properties in animal experiments. To study the bioavailability, kinetics and effects of isothiocyanates from cruciferous vegetables, biomarkers of exposure and for selected beneficial effects were developed and validated. As a biomarker for intake and bioavailability, isothiocyanate mercapturic acids were chemically synthesised as reference compounds and a method for their quantification in urine was developed.
    [Show full text]
  • Enhancement of Broccoli Indole Glucosinolates by Methyl Jasmonate Treatment and Effects on Prostate Carcinogenesis
    JOURNAL OF MEDICINAL FOOD J Med Food 17 (11) 2014, 1177–1182 # Mary Ann Liebert, Inc., and Korean Society of Food Science and Nutrition DOI: 10.1089/jmf.2013.0145 Enhancement of Broccoli Indole Glucosinolates by Methyl Jasmonate Treatment and Effects on Prostate Carcinogenesis Ann G. Liu,1 John A. Juvik,2 Elizabeth H. Jeffery,1 Lisa D. Berman-Booty,3 Steven K. Clinton,4 and John W. Erdman, Jr.1 1Division of Nutritional Sciences, Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. 2Department of Crop Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. 3Department of Veterinary Biosciences and 4Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA. ABSTRACT Broccoli is rich in bioactive components, such as sulforaphane and indole-3-carbinol, which may impact cancer risk. The glucosinolate profile of broccoli can be manipulated through treatment with the plant stress hormone methyl jasmonate (MeJA). Our objective was to produce broccoli with enhanced levels of indole glucosinolates and determine its impact on prostate carcinogenesis. Brassica oleracea var. Green Magic was treated with a 250 lM MeJA solution 4 days prior to harvest. MeJA-treated broccoli had significantly increased levels of glucobrassicin, neoglucobrassicin, and gluconasturtiin (P < .05). Male transgenic adenocarcinoma of mouse prostate (TRAMP) mice (n = 99) were randomized into three diet groups at 5–7 weeks of age: AIN-93G control, 10% standard broccoli powder, or 10% MeJA broccoli powder. Diets were fed throughout the study until termination at 20 weeks of age. Hepatic CYP1A was induced with MeJA broccoli powder feeding, indicating biological activity of the indole glucosinolates.
    [Show full text]
  • Advances in Nanomaterials As Novel Elicitors of Pharmacologically Active
    RSC Advances View Article Online REVIEW View Journal | View Issue Advances in nanomaterials as novel elicitors of pharmacologically active plant specialized Cite this: RSC Adv.,2019,9, 40404 metabolites: current status and future outlooks Sumaira Anjum, *a Iram Anjum,a Christopher Hano b and Sidra Kousarc During the last few decades major advances have shed light on nanotechnology. Nanomaterials have been widely used in various fields such as medicine, energy, cosmetics, electronics, biotechnology and pharmaceuticals. Owing to their unique physicochemical characteristics and nanoscale structures, nanoparticles (NPs) have the capacity to enter into plant cells and interact with intracellular organelles and various metabolites. The effects of NPs on plant growth, development, physiology and biochemistry have been reported, but their impact on plant specialized metabolism (aka as secondary metabolism) still remains obscure. In reaction to environmental stress and elicitors, a common response in plants results in the production or activation of different types of specialized metabolites (e.g., alkaloids, terpenoids, Creative Commons Attribution 3.0 Unported Licence. phenolics and flavonoids). These plant specialized metabolites (SMs) are important for plant adaptation to an adverse environment, but also a huge number of them are biologically active and used in various commercially-valued products (pharmacy, cosmetic, agriculture, food/feed). Due to their wide array of applications, SMs have attracted much attention to explore and develop new strategies to enhance their production in plants. In this context, NPs emerged as a novel class of effective elicitors to enhance the production of various plant SMs. In recent years, many reports have been published regarding the elicitation of SMs by different types of NPs.
    [Show full text]
  • Glucosinolates As Undesirable Substances in Animal Feed1
    The EFSA Journal (2008) 590, 1-76 Glucosinolates as undesirable substances in animal feed1 Scientific Panel on Contaminants in the Food Chain (Question N° EFSA-Q-2003-061) Adopted on 27 November 2007 PANEL MEMBERS Jan Alexander, Guðjón Atli Auðunsson, Diane Benford, Andrew Cockburn, Jean-Pierre Cravedi, Eugenia Dogliotti, Alessandro Di Domenico, Maria Luisa Férnandez-Cruz, Peter Fürst, Johanna Fink-Gremmels, Corrado Lodovico Galli, Philippe Grandjean, Jadwiga Gzyl, Gerhard Heinemeyer, Niklas Johansson, Antonio Mutti, Josef Schlatter, Rolaf van Leeuwen, Carlos Van Peteghem and Philippe Verger. SUMMARY Glucosinolates (alkyl aldoxime-O-sulphate esters with a β-D-thioglucopyranoside group) occur in important oil- and protein-rich agricultural crops, including among others Brassica napus (rapeseed of Canola), B. campestris (turnip rape) and Sinapis alba (white mustard), all belonging to the plant family of Brassicaceae. They are present in all parts of these plants, with the highest concentrations often found in seeds. Several of these Brassica species are important feed ingredients and some species are also commonly used in human nutrition such as cauliflower, cabbages, broccoli and Brussels sprouts. Glucosinolates and their breakdown products determine the typical flavour and (bitter) taste of these vegetables. 1For citation purposes: Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the European Commission on glucosinolates as undesirable substances in animal feed, The EFSA Journal (2008) 590, 1- 76 © European Food Safety Authority, 2008 Glucosinolates as undesirable substances in animal feed The individual glucosinolates vary in structure and the configuration of their side chain. They are hydrophilic and rather stable and remain in the press cake of oilseeds when these are processed and de-oiled.
    [Show full text]
  • The Role of Isothiocyanates As Cancer Chemo‐Preventive, Chemo
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Papers in Veterinary and Biomedical Science Veterinary and Biomedical Sciences, Department of 2019 The Role of Isothiocyanates as Cancer Chemo‐Preventive, Chemo‐Therapeutic and Anti‐Melanoma Agents Melina Mitsiogianni Northumbria University, [email protected] Georgios Koutsidis Northumbria University, [email protected] Nikos Mavroudis University of Reading, [email protected] Dimitrios T. Trafalis University of Athens, [email protected] Sotiris Botaitis Democritus University of Thrace, [email protected] SeFoe nelloxtw pa thige fors aaddndition addal aitutionhorsal works at: https://digitalcommons.unl.edu/vetscipapers Part of the Biochemistry, Biophysics, and Structural Biology Commons, Cell and Developmental Biology Commons, Immunology and Infectious Disease Commons, Medical Sciences Commons, Veterinary Microbiology and Immunobiology Commons, and the Veterinary Pathology and Pathobiology Commons Mitsiogianni, Melina; Koutsidis, Georgios; Mavroudis, Nikos; Trafalis, Dimitrios T.; Botaitis, Sotiris; Franco, Rodrigo; Zoumpourlis, Vasilis; Amery, Tom; Galanis, Alex; Pappa, Aglaia; and Panayiotidis, Mihalis I., "The Role of Isothiocyanates as Cancer Chemo‐Preventive, Chemo‐Therapeutic and Anti‐Melanoma Agents" (2019). Papers in Veterinary and Biomedical Science. 319. https://digitalcommons.unl.edu/vetscipapers/319 This Article is brought to you for free and open access by the Veterinary and Biomedical Sciences,
    [Show full text]